Lv1
60 积分 2024-01-04 加入
Advances in the management of endometrial cancer
1天前
已完结
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
1个月前
已完结
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
1个月前
已完结
Dynamic susceptibility contrast perfusion MRI helps in differentiating double-expressor from non-double-expressor subtypes in primary central nervous system lymphoma
2个月前
已完结
Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review
2个月前
已完结
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature
2个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
3个月前
已完结
Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer
5个月前
已完结
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
5个月前
已完结
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
5个月前
已完结
皖公网安备34019202002308
